Clinical Trial Update: Bryostatin-1 Effect on HIV-1 Latency and Reservoir in HIV-1 Infected Patients Receiving Antiretroviral Treatment [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating Bryostatin-1 for its effect on HIV-1 latency and reservoirs in patients on antiretroviral therapy has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Bryostatin-1 (bryostatin-1)

Snippet

Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | Conditions: HIV Infection | Phase 1 | Status: COMPLETED